AUG 7, 2026 · PHASE 2 TRIAL
Study to Evaluate the Safety and Tolerability of Camizestrant in Combination With Atirmociclib in Women With Advanced Breast Cancer
ClinicalTrials.gov
This is a recruiting Phase 2 study with no results posted; it describes a planned safety and tolerability evaluation in a small population with an estimated 24 participants.
Reported
Planned enrollment24
Study phasePhase 2
Primary outcome measureNumber of participants with adverse events…